Hepatitis C Information Central


Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information

News, Updates and Commentary

Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Acute Hepatitis C from Unsafe Injections
Disease The CDC has concluded an investigation of a clinic in Nevada that reported an outbreak of Hepatitis C Virus (HCV) in 6 people that resulted from unsafe injection procedures. Here's what happened:Hepatitis C is a reportable infection to the

CDC: Syringe reuse linked to hepatitis C outbreak
Sorry, unavailable at this time.

Free blood test for widespread hepatitis B
A quarter century after the first hepatitis B vaccine became commercially available, rates of acute infection with the liver-scarring virus have plummeted in the United States, but the disease remains endemic in Asia - and 1 in 10 of the estimated 10.3


UPDATES AND COMMENTARY RSS Feed

What You Must Know About Alcoholic Hepatitis
This much-needed synopsis of alcoholic hepatitis reminds us that you don't need to be a heavy drinker to suffer from this condition. Looking over the causes, risk factors and complications of alcoholic hepatitis will motivate anyone with liver concerns to...

15 Tips for Managing Interferon-Ribavirin Side Effects
Finding new ways to manage the side effects of Hepatitis C combination therapy adds to a person’s likelihood of conquering the virus....

New Mexico Offers Free Hepatitis C Hotline
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...



Hepatology 1996 Apr;23(4):695-699

The natural course of chronic Hepatitis C:
A comparison between patients with genotypes 1 and 2 Hepatitis C viruses.

Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K

The Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

This study was conducted to clarify if the long-term histological outcome among patients with chronic Hepatitis C differs according to whether they are infected with genotype 1 or 2 Hepatitis C virus (HCV). We examined 140 patients with chronic Hepatitis C. The HCV genotype was determined by the enzyme-linked immunosorbent assay (ELISA) based on genotypes 1 and 2 specific recombinant proteins; genotype 1 was found in 100 patients (96 were 1b and 4 were indeterminate) and genotype 2 in 36. The two groups showed no significant difference for any clinical background features. Deterioration of the grade of liver histology during the follow-up period was seen in 68.0 percent of the patients with genotype 1 as compared with 41.7 percent of those with genotype 2 (P < .01). Similarly, the deterioration of the stage of liver histology was more common in the former group than in the latter (63.0 percent and 38.9 percent respectively; P < .05). The mean serum HCV-RNA titer was significantly higher in the patients with genotype 1 than in those with genotype 2 (P < .001), and multivariate analysis showed the titer was one of the independent factors of the deterioration of the stage (P = .0044). This phenomenon may be related in part to the difference in pathogenicity between the two HCV genotypes. In conclusion, our results suggest that more severe progression of chronic Hepatitis C is seen in patients showing genotype 1b compared with those with genotype 2.

PMID: 8666319, UI: 96230089

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 18 May 2008